ArticleScientific reports2025
Oral administration of crocin significantly alleviated anxiety, and depressive-like behavior following ethanol and nicotine abstinence in adolescent male rats.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There are increasing concerns about nicotine (Nic) and ethanol (Eth) dependence and more importantly the detrimental effects of Nic abstinence among adolescents. The present study aims to assess the effects of crocin main constituent of saffron on anxiety, and depressive like behavior caused by withdrawal following co-abuse of Eth and Nic by assessing related behavioral and biochemical analysis. To this end, behavioral tests including elevated plus maze, open field and forced swimming tests alongside related biochemical analysis were done in which experienced abstinence or treated with crocin. Nic-Eth abstinence induced anxiety- and depressive-like symptoms, whereas both doses of crocin (20 and 30 mg/kg) decreased anxiety and depression induced by Nic-Eth abstinence. In biochemical analysis, crocin as well as buprenorphine-naloxone (Bup-Nal) improved the both oxidative/antioxidant and inflammatory/anti-inflammatory biomarkers balance. Furthermore, serotonin significantly increased in Nic-Eth group treated with either crocin or Bup-Nal. In addition, MAO activity significantly increased in Nic-Eth group, whereas treatment of that with crocin as well as Bup-Nal notably attenuated MAO activity. BDNF notably increased in Nic-Eth group treated with crocin and Bup-Nal. Considering previous results, crocin have a wide range of pharmacological effects, and the present findings also confirmed that it has strong potential to be effective in anxiety, and depressive-like behavior occurred in withdrawal following Nic and Eth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.